References
- Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55(3):173–183. http://www.ncbi.nlm.nih.gov/pubmed/17456933. Accessed September 7, 2017.
- Cunningham ET. Diagnosing and treating herpetic anterior uveitis. Ophthalmology. 2000;107(12):2129–2130. http://www.ncbi.nlm.nih.gov/pubmed/11097582. Accessed September 7, 2017.
- Gaynor BD, Margolis TP, Cunningham ET. Advances in diagnosis and management of herpetic uveitis. Int Ophthalmol Clin. 2000;40(2):85–109. http://www.ncbi.nlm.nih.gov/pubmed/10791259. Accessed September 7, 2017.
- London NJS, Rathinam SR, Cunningham ET. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50(2):1–17. doi:10.1097/IIO.0b013e3181d2cc6b.
- Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 Suppl):S3–12. doi:10.1016/j.ophtha.2007.10.009.
- Hoeksema L, Los LI. Vision-related quality of life in herpetic anterior uveitis patients. PLoS One. 2014;9(1). doi:10.1371/journal.pone.0085224.
- Takase H, Kubono R, Terada Y, et al. Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol. 2014;58(6):473–482. doi:10.1007/s10384-014-0340-6.
- Wensing B, Mochizuki M, De Boer JH. Clinical characteristics of herpes simplex virus associated anterior uveitis. Ocul Immunol Inflamm. January 2018:1–5. doi:10.1080/09273948.2017.1420806.
- Miserocchi E, Fogliato G, Bianchi I, Bandello F, Modorati G. Clinical features of ocular herpetic infection in an Italian referral center. Cornea. 2014;33(6):565–570. doi:10.1097/ICO.0000000000000129.
- Liesegang TJ. The biology of herpes simplex and varicella zoster virus infections. Int Ophthalmol Clin. 1993;33(1):81–93. http://www.ncbi.nlm.nih.gov/pubmed/8394293. Accessed December 2, 2017.
- Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol. 2010;30(5):559–565. doi:10.1007/s10792-010-9394-8.
- Kardeş E, Bozkurt K, Sezgin Akçay Bİ, Ünlü C, Aydoğan Gezginaslan T, Ergin A. Clinical features and prognosis of herpetic anterior uveitis. Türk Oftalmol Derg. 2016;46(3):109–113. doi:10.4274/tjo.92053.
- Nalcacioglu-Yüksekkaya P, Ozdal PC, Teke MY, Kara C, Ozturk F. Presumed herpetic anterior uveitis: a study with retrospective analysis of 79 cases. Eur J Ophthalmol. 2013;24(1):14–20. doi:10.5301/ejo.5000331.
- Van der Lelij A, Ooijman FM, Kijlstra A, Rothova A. Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology. 2000;107(6):1164–1170. doi:10.1016/S0161-6420(00)00115-9.
- Usui M, Usui N, Goto H, Minoda H, Rai T. Polymerase chain reaction for diagnosis of herpetic intraocular inflammation. Ocul Immunol Inflamm. 1993;1(1–2):105–112. doi:10.3109/09273949309086545.
- Yamamoto S, Pavan-Langston D, Kinoshita S, Nishida K, Shimomura Y, Tano Y. Detecting herpesvirus DNA in uveitis using the polymerase chain reaction. Br J Ophthalmol. 1996;80(5):465–468. http://www.ncbi.nlm.nih.gov/pubmed/8695570. Accessed December 2, 2017.
- Sugita S, Ogawa M, Shimizu N, et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120(9):1761–1768. doi:10.1016/j.ophtha.2013.02.020.
- Wilhelmus KR, Beck RW, Moke PS, et al. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med. 1998;339(5):300–306. doi:10.1056/NEJM199807303390503.
- Lairson DR, Begley CE, Reynolds TF, Wilhelmus KR. Prevention of herpes simplex virus eye disease. Arch Ophthalmol. 2003;121(1):108. doi:10.1001/archopht.121.1.108.
- Sudesh S, Laibson PR. The impact of the Herpetic Eye Disease Studies on the management of herpes simplex virus ocular infections. Curr Opin Ophthalmol. 1999;10(4):230–233. doi:10.1097/00055735-199908000-00002.
- Khan BF, Pavan-Langston D. Clinical manifestations and treatment modalities in herpes simplex virus of the ocular anterior segment. Int Ophthalmol Clin. 2004;44(3):103–133. https://insights.ovid.com/pubmed?pmid=15211181. Accessed December 2, 2017.
- Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516. http://www.ncbi.nlm.nih.gov/pubmed/16196117. Accessed December 2, 2017.
- Zhou Y, Eubanks N, Dien Bard J Detection of HSV-1/2 and VZV using Real-Time PCR and the altona RealStar® alpha Herpesvirus Assay. Poster presentation at Clinical Virology Symposium; April 27–30, 2014; Daytona Beach, FL.
- Berth M, Benoy I, Christensen N. Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients. Eur J Clin Microbiol Infect Dis. 2016;35(2):245–249. doi:10.1007/s10096-015-2537-0.
- Wensing B, Relvas LM, Caspers LE, et al. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology. 2011;118(10):1905–1910. doi:10.1016/j.ophtha.2011.03.033.
- Mochizuki M, Sugita S, Kamoi K, Takase H. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol. 2017;61(1):1–20. doi:10.1007/s10384-016-0474-9.
- Chee S, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94(12):1648–1652. doi:10.1136/bjo.2009.167767.
- Woo JH, Lim WK, Ho SL, Teoh SC. Characteristics of cytomegalovirus uveitis in immunocompetent patients. Ocul Immunol Inflamm. 2015;23(5):378–383. doi:10.3109/09273948.2014.950384.
- Chee S-P, Bascal K, Jap A, Se-Thoe S-Y, Cheng CL, Tan ABH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;146(4):625. doi:10.1016/j.ajo.2008.06.013.
- Markomichelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G. Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology. 2002;109(5):879–882. doi:10.1016/S0161-6420(02)00961-2.
- Relvas LJM, Antoun J, de Groot-Mijnes JDF, et al. Diagnosis of cytomegalovirus anterior uveitis in two European referral centers. Ocul Immunol Inflamm. 2018;26(1):116–121. doi:10.1080/09273948.2017.1411952.
- de-la-Torre A, Valdes-Camacho J, Foster CS. Bilateral herpes simplex uveitis: review of the literature and own reports. Ocul Immunol Inflamm. 2017;25(4):497–502. doi:10.3109/09273948.2016.1142572.
- Rodriguez A, Power WJ, Neves RA, Foster CS. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir. Doc Ophthalmol. 1995;90(4):331–340. https://link.springer.com/content/pdf/10.1007%2FBF01268121.pdf. Accessed March 4, 2018.
- Baldwin J, Park PJ, Zanotti B, et al. Susceptibility of human iris stromal cells to herpes simplex virus 1 entry. J Virol. 2013;87(7):4091–4096. doi:10.1128/JVI.03235-12.
- Shirane M. Expression of herpes simplex associated antigens in ocular tissues following induced herpetic anterior uveitis. Jpn J Ophthalmol. 1996;40(4):491–501. http://www.ncbi.nlm.nih.gov/pubmed/9130053. Accessed March 4, 2018.
- Pepose JS. Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol. 1991;35(5):345–352. doi:10.1016/0039-6257(91)90184-H.